Bild von Hannes Mikula

© Tiss: Hannes Mikula

Univ.Prof. Dipl.-Ing. Dr.techn. Hannes Mikula was appointed as University Professor for Chemical Biology at TU Wien with effect from October 1, 2023. He is assigned to the Institute of Applied Synthetic Chemistry, opens an external URL in a new window (E163) at the Faculty of Technical Chemistry, opens an external URL in a new window.

Hannes Mikula comes from Burgenland. He studied technical chemistry at the TU Wien and completed his doctoral studies here in 2014 with a doctorate sub auspiciis on the topic "Advanced synthesis of conjugated metabolites and structural investigations of Fusarium and Alternaria Mycotoxins, opens an external URL in a new window". Supported by an Erwin Schrödinger scholarship from the FWF, he then moved to the Massachusetts General Hospital & Harvard Medical School, opens an external URL in a new window in Boston (USA) as a postdoctoral fellow before returning to the TU Wien in 2016. From 2016 to 2021, his group was, among other things, significantly involved in the EU project “Click-it, opens an external URL in a new window”. The Zukunftskolleg, opens an external URL in a new window, which has been coordinated by Hannes Mikula since 2019 and funded by the FWF, enabled him to get a career position on the topic of Chemical Biology in 2021. In 2021, a START Prize, opens an external URL in a new window from the FWF was obtained, followed by an ERC Starting Grant [TUW News article, opens an external URL in a new window] the following year. After completing his habilitation process in 2022, he successfully completed his career position by qualifying as an associate professor.

Hannes Mikula's scientific home is Research Unit of Organic and Biological Chemistry at the aforementioned institute and Research Group for Molecular Chemistry and Chemical Biology, opens an external URL in a new window there, which he also heads. His research focuses, among other things, on the application of “click chemistry, opens an external URL in a new window” and bioorthogonal reactions in order to develop new molecular technologies and, based on them, therapeutic strategies, for example for the treatment of cancer.

Publications by Hannes Mikula in the Scopus, opens an external URL in a new window database and in ReposiTUm, opens an external URL in a new window.